255 related articles for article (PubMed ID: 20605778)
1. Purinergic receptor-mediated rapid depletion of nuclear phosphorylated Akt depends on pleckstrin homology domain leucine-rich repeat phosphatase, calcineurin, protein phosphatase 2A, and PTEN phosphatases.
Mistafa O; Ghalali A; Kadekar S; Högberg J; Stenius U
J Biol Chem; 2010 Sep; 285(36):27900-10. PubMed ID: 20605778
[TBL] [Abstract][Full Text] [Related]
2. Silencing p110β prevents rapid depletion of nuclear pAkt.
Ye ZW; Ghalali A; Högberg J; Stenius U
Biochem Biophys Res Commun; 2011 Dec; 415(4):613-8. PubMed ID: 22074824
[TBL] [Abstract][Full Text] [Related]
3. Atorvastatin prevents ATP-driven invasiveness via P2X7 and EHBP1 signaling in PTEN-expressing prostate cancer cells.
Ghalali A; Wiklund F; Zheng H; Stenius U; Högberg J
Carcinogenesis; 2014 Jul; 35(7):1547-55. PubMed ID: 24451147
[TBL] [Abstract][Full Text] [Related]
4. Statins exhibit anticancer effects through modifications of the pAkt signaling pathway.
Miraglia E; Högberg J; Stenius U
Int J Oncol; 2012 Mar; 40(3):867-75. PubMed ID: 21994073
[TBL] [Abstract][Full Text] [Related]
5. Statins and ATP regulate nuclear pAkt via the P2X7 purinergic receptor in epithelial cells.
Mistafa O; Högberg J; Stenius U
Biochem Biophys Res Commun; 2008 Jan; 365(1):131-6. PubMed ID: 17980145
[TBL] [Abstract][Full Text] [Related]
6. PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1.
Radu A; Neubauer V; Akagi T; Hanafusa H; Georgescu MM
Mol Cell Biol; 2003 Sep; 23(17):6139-49. PubMed ID: 12917336
[TBL] [Abstract][Full Text] [Related]
7. Statins inhibit Akt/PKB signaling via P2X7 receptor in pancreatic cancer cells.
Mistafa O; Stenius U
Biochem Pharmacol; 2009 Nov; 78(9):1115-26. PubMed ID: 19540829
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological inhibition of pleckstrin homology domain leucine-rich repeat protein phosphatase is neuroprotective: differential effects on astrocytes.
Jackson TC; Verrier JD; Drabek T; Janesko-Feldman K; Gillespie DG; Uray T; Dezfulian C; Clark RS; Bayir H; Jackson EK; Kochanek PM
J Pharmacol Exp Ther; 2013 Nov; 347(2):516-28. PubMed ID: 24023368
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells.
Tang Y; Berlind J; Mavila N
Cell Commun Signal; 2018 Mar; 16(1):9. PubMed ID: 29530069
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D arrests thyroid carcinoma cell growth and induces p27 dephosphorylation and accumulation through PTEN/akt-dependent and -independent pathways.
Liu W; Asa SL; Fantus IG; Walfish PG; Ezzat S
Am J Pathol; 2002 Feb; 160(2):511-9. PubMed ID: 11839571
[TBL] [Abstract][Full Text] [Related]
11. Notch1 receptor regulates AKT protein activation loop (Thr308) dephosphorylation through modulation of the PP2A phosphatase in phosphatase and tensin homolog (PTEN)-null T-cell acute lymphoblastic leukemia cells.
Hales EC; Orr SM; Larson Gedman A; Taub JW; Matherly LH
J Biol Chem; 2013 Aug; 288(31):22836-48. PubMed ID: 23788636
[TBL] [Abstract][Full Text] [Related]
12. Cytosolic phospholipase A2α sustains pAKT, pERK and AR levels in PTEN-null/mutated prostate cancer cells.
Hua S; Yao M; Vignarajan S; Witting P; Hejazi L; Gong Z; Teng Y; Niknami M; Assinder S; Richardson D; Dong Q
Biochim Biophys Acta; 2013 Jun; 1831(6):1146-57. PubMed ID: 23500889
[TBL] [Abstract][Full Text] [Related]
13. Relationship between polycomb-group protein BMI-1 and phosphatases regulating AKT phosphorylation level in endometrial cancer.
Zaczek A; Jóźwiak P; Ciesielski P; Forma E; Wójcik-Krowiranda K; Cwonda Ł; Bieńkiewicz A; Bryś M; Krześlak A
J Cell Mol Med; 2020 Jan; 24(2):1300-1310. PubMed ID: 31863623
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of atorvastatin on the cell growth of cardiac myxomas via the PTEN and PHLPP2 phosphatase signaling pathway.
Wu XL; Yang DY; Tan DJ; Yao HC; Chai W; Peng L
Oncol Rep; 2013 Aug; 30(2):757-62. PubMed ID: 23715723
[TBL] [Abstract][Full Text] [Related]
15. Influence of zinc deficiency on Akt-Mdm2-p53 and Akt-p21 signaling axes in normal and malignant human prostate cells.
Han CT; Schoene NW; Lei KY
Am J Physiol Cell Physiol; 2009 Nov; 297(5):C1188-99. PubMed ID: 19657064
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin inhibits GSK-3beta phosphorylation by cardiac hypertrophic stimuli.
Planavila A; Rodríguez-Calvo R; Palomer X; Coll T; Sánchez RM; Merlos M; Laguna JC; Vázquez-Carrera M
Biochim Biophys Acta; 2008; 1781(1-2):26-35. PubMed ID: 18036354
[TBL] [Abstract][Full Text] [Related]
17. Synemin promotes AKT-dependent glioblastoma cell proliferation by antagonizing PP2A.
Pitre A; Davis N; Paul M; Orr AW; Skalli O
Mol Biol Cell; 2012 Apr; 23(7):1243-53. PubMed ID: 22337773
[TBL] [Abstract][Full Text] [Related]
18. Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression.
Patel R; Gao M; Ahmad I; Fleming J; Singh LB; Rai TS; McKie AB; Seywright M; Barnetson RJ; Edwards J; Sansom OJ; Leung HY
J Clin Invest; 2013 Mar; 123(3):1157-75. PubMed ID: 23434594
[TBL] [Abstract][Full Text] [Related]
19. Loss of PTEN expression does not contribute to PDK-1 activity and PKC activation-loop phosphorylation in Jurkat leukaemic T cells.
Freeley M; Park J; Yang KJ; Wange RL; Volkov Y; Kelleher D; Long A
Cell Signal; 2007 Dec; 19(12):2444-57. PubMed ID: 17826953
[TBL] [Abstract][Full Text] [Related]
20. Identification of a tumour suppressor network opposing nuclear Akt function.
Trotman LC; Alimonti A; Scaglioni PP; Koutcher JA; Cordon-Cardo C; Pandolfi PP
Nature; 2006 May; 441(7092):523-7. PubMed ID: 16680151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]